Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 HKD | -0.85% | -7.87% | -48.68% |
Sales 2024 * | - | Sales 2025 * | 181M 24.95M 195M | Capitalization | 791M 109M 854M |
---|---|---|---|---|---|
Net income 2024 * | -528M -72.92M -570M | Net income 2025 * | -412M -56.9M -445M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.38 x |
P/E ratio 2024 * |
-1.67
x | P/E ratio 2025 * |
-3.1
x | Employees | 128 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.51% |
Latest transcript on Brii Biosciences Limited
1 day | -0.85% | ||
1 week | -7.87% | ||
1 month | -6.40% | ||
3 months | -29.52% | ||
6 months | -58.06% | ||
Current year | -48.68% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Hong
CEO | Chief Executive Officer | 60 | 17-12-07 |
An Kang Li
DFI | Director of Finance/CFO | 47 | 20-08-31 |
David Margolis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 21-06-21 |
Tai Yin Yang
BRD | Director/Board Member | 70 | 22-08-31 |
Robert Nelsen
BRD | Director/Board Member | 60 | 18-06-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.53% | 4 M€ | -27.92% | ||
0.00% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.17 | -0.85% | 912,500 |
24-05-30 | 1.18 | -3.28% | 1,060,500 |
24-05-29 | 1.22 | -1.61% | 900,931 |
24-05-28 | 1.24 | -3.13% | 1,068,000 |
24-05-27 | 1.28 | +0.79% | 767,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.68% | 109M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- 2137 Stock